Recurrent facial keratoacanthoma in a patient with diabetes: A case report

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Omar, Esam ^a  

^a TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Recurrent keratoacanthoma; Report

Indexed keywords

CASE REPORT; COMPLICATION; DIABETES MELLITUS; FACE; HUMAN; KERATOACANTHOMA; MALE; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE;

DIABETES COMPLICATIONS; FACE; HUMANS; KERATOACANTHOMA; MALE; MIDDLE AGED; RECURRENCE;

EID: 84901452438     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-257     Document Type: Article

References (13)

1. Keratoacanthoma: is it a real entity? Manstein CH, Frauenhoffer CJ, Besden JE, Ann Plast Surg 1998 40 5 469 472 10.1097/00000637-199805000-00004 9600429 (Pubitemid 28215516)
2. Keratoacanthoma. Schwartz RA, J Am Acad Dermatol 1994 30 1 1 19 10.1016/S0190-9622(94)70001-X 8277007 (Pubitemid 24033812)
3. Diagnosis and follow-up of keratoacanthoma-like lesions: clinical-histologic study of 43 cases. Magalhaes RF, Cruvinel GT, Cintra GF, Cintra ML, Ismael AP, de Moraes AM, J Cutan Med Surg 2008 12 4 163 173 18627696
4. Keratoacanthoma and infundibulocystic squamous cell carcinoma. Kossard S, Tan KB, Choy C, Am J Dermatopathol 2008 30 2 127 134 10.1097/DAD. 0b013e318161310c 18360115 (Pubitemid 351441984)
5. Multiple painful keratoacanthomas. Frank TL, Maguire HC Jr, Greenbaum SS, Int J Dermatol 1996 35 9 648 650 10.1111/j.1365-4362.1996.tb03691.x 8876293 (Pubitemid 26298323)
6. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: case report and review of a controversial therapy. Sanders S, Busam KJ, Halpern AC, Nehal KS, Dermatol Surg 2002 28 10 954 958 10.1046/j.1524-4725.2002.02069.x 12410683 (Pubitemid 35215818)
7. Non-melanoma skin cancer and keratoacanthoma in Filipinos: an incidence report from Kauai, Hawaii. Chuang TY, Reizner GT, Elpern DJ, Stone JL, Farmer ER, Int J Dermatol 1993 32 10 717 718 10.1111/j.1365-4362.1993.tb02740.x 8225710 (Pubitemid 23326981)
8. Keratoacanthoma in Kauai, Hawaii. The first documented incidence in a defined population. Chuang TY, Reizner GT, Elpern DJ, Stone JL, Farmer ER, Arch Dermatol 1993 129 3 317 319 10.1001/archderm.1993.01680240057005 8447667 (Pubitemid 23077446)
9. Basal cell carcinoma and keratoacanthoma in Hawaiians: an incidence report. Reizner GT, Chuang TY, Elpern DJ, Stone JL, Farmer ER, J Am Acad Dermatol 1993 29 5 Pt 1 780 782 8227552 (Pubitemid 23327980)
10. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. Annest NM, VanBeek MJ, Arpey CJ, Whitaker DC, J Am Acad Dermatol 2007 56 6 989 993 10.1016/j.jaad.2006.12.017 17504715 (Pubitemid 46720214)
11. Treatment of keratoacanthoma with intralesional bleomycin. Sayama S, Tagami H, Br J Dermatol 1983 109 4 449 452 10.1111/j.1365-2133.1983.tb04619.x 6194810 (Pubitemid 13012293)
12. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Dendorfer M, Oppel T, Wollenberg A, Prinz JC, Eur J Dermatol 2003 13 1 80 82 12609789 (Pubitemid 36228516)
13. Persistent keratoacanthoma: challenges in management. Canas GC, Robson KJ, Arpey CJ, Canas GC, Robson KJ, Arpey CJ, Dermatol Surg 1998 24 12 1364 1369 10.1111/j.1524-4725.1998.tb00016.x 9865205